Aeglea BioTherapeutics

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell AGLE and other ETFs, options, and stocks.

About AGLE

Aeglea Biotherapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of next-generation human enzyme therapeutics as disruptive solutions for rare and other high-burden diseases. Its product Pegzilarginase, is in a Phase 3 pivotal trial for the treatment of Arginase 1 Deficiency. 

CEO
Jim Kastenmayer
CEOJim Kastenmayer
Employees
101
Employees101
Headquarters
Austin, Texas
HeadquartersAustin, Texas
Founded
2013
Founded2013
Employees
101
Employees101

AGLE Key Statistics

Market cap
32.30M
Market cap32.30M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
254.71K
Average volume254.71K
High today
$0.57
High today$0.57
Low today
$0.51
Low today$0.51
Open price
$0.57
Open price$0.57
Volume
537.70K
Volume537.70K
52 Week high
$8.50
52 Week high$8.50
52 Week low
$0.372
52 Week low$0.372

Analyst ratings

50%

of 6 ratings
Buy
50%
Hold
50%
Sell
0%

AGLE Earnings

-$0.37
-$0.25
-$0.12
$0.00
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
per share
Estimated per share
Actual
Expected Nov 3, Pre-Market
ActualExpected Nov 3, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.